BCAB vs CL · $5.9M cap vs P/E 34, rev $20.38B
Bioatla Inc (BCAB) versus Colgate-Palmolive Company (CL) — a side-by-side from cached financials, not a winner call.
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
BCAB currently screens at market cap $5.9M. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Not investment advice. Open the BCAB and CL stock pages for the full models.
Not investment advice.